Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0005 | 1 |
mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.0005 | 1 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |